Skip to main content
SpringerLink
Log in

German committee can’t omit drugs from guidelines on efficacy grounds

  • Newsletter Article
  • Published:
PharmacoEconomics & Outcomes News Weekly

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

German committee can’t omit drugs from guidelines on efficacy grounds. Pharmacoecon. Outcomes News 109, 11 (1997). https://doi.org/10.1007/BF03271543

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03271543

Keywords

Search

Navigation